MarginsXMarginsX
Home › Markets › Health Care › VOGX

Vogenx Inc (VOGX)

VOGX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$14.38
-13.74% on the day
Market cap
$213.6M
Micro cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerVOGX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2026
SEC CIK0001903784
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
11.2 months
$5.1M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"Accordingly, management concluded that substantial doubt regarding the Company's ability to continue as a going concern does not exist. 5 Table of Contents Reverse stock split On July 21, 2026 the Company's board of directors approved a one-for-three reverse stock split, which was effected on July 28, 2026, of the Company's issued and outstanding shares of common stock."
10-Q 2026-11-06
Cash and burn$5.1M cash; operating cash flow -$1.4M a quarter.Report 2026-09-30
Shares outstanding14,855,087 (2026-11-05).Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., Raleigh, North Carolina, United StatesPCAOB Form AP 2026-08-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$4.9M-$2.6M$5.1M$0Needs four quarters10-Q 2026-11-06
Q3 2026
2026-06-30
Not filed-$384KNot filed$193K$868KNeeds four quarters10-Q 2026-11-06
Q3 2026
2026-03-31
Not filed-$475KNot filedNot filedNo debt tagsNeeds four quarters10-Q 2026-11-06
Q3 2026
2025-09-30
Not filed-$284K-$156K$234KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q3 2026
2025-06-30
Not filed-$295KNot filed$390KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q3 2026
2025-03-31
Not filed-$357KNot filedNot filedNo debt tagsNeeds four quarters10-Q 2026-11-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B4
424B42026-08-12
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-06
Latest current report
FORM 8-K
8-K2026-11-06

Source: SEC EDGAR submissions feed, 43 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.5%
1 month-0.5%
3 months+18.3%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-51.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ACIUAC Immune SA$2.09-1.88%$212.7M
YARWYarrow Bioscience Inc.$13.93-22.74%$212.2M
CYPHCypherpunk Technologies Inc.$1.93+2.94%$207.4M
DRUGBright Minds Biosciences Inc.$22.61-2.16%$222.0M
SIGASIGA Technologies Inc.$2.85+4.01%$204.8M
BCYCBicycle Therapeutics plc$3.18-5.64%$222.9M
GLSIGreenwich LifeSciences Inc.$13.76-7.90%$202.0M
IMRXImmuneering Corporation$3.52-5.12%$228.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier